Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
27.06
-0.46 (-1.67%)
Sep 15, 2025, 2:33 PM EDT - Market open
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $391.98 million as of September 15, 2025. Its market cap has increased by 90.82% in one year.
Market Cap
391.98M
Enterprise Value
318.57M
1-Year Change
90.82%
Ranking
Category
Stock Price
$27.06
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $391.98M, an increase of 97.73%. That is a compound annual growth rate of 69.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 398.64M | 78.82% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |